Retrospective Cohort Study
Copyright ©The Author(s) 2018.
World J Gastroenterol. Jan 7, 2018; 24(1): 58-68
Published online Jan 7, 2018. doi: 10.3748/wjg.v24.i1.58
Table 1 Clinicopathologic features of the hepatitis C virus-hepatocellular carcinoma and hepatitis B virus-hepatocellular carcinoma n (%)
HCV (n = 273)HBV (n = 68)P value
Age (mean ± SD)67.16 ± 8.5657.15 ± 12.47< 0.0001
Gender
Male203 (74.36)59 (86.76)0.0300
Female70 (25.64)9 (13.24)
Smoking habit
Never111 (40.66)21 (30.88)0.0715
Ex74 (27.11)15 (22.06)
Current88 (32.23)32 (47.06)
Alcohol abuse
(+)63 (23.08)22 (32.35)0.1136
(-)210 (76.92)46 (67.65)
Diabetes mellitus
(+)62 (22.71)12 (17.65)0.3647
(-)211 (77.29)56 (82.35)
BMI (mean ± SD)22.49 ± 3.2922.93 ± 3.800.3478
ICG R15 (%) (mean ± SD)18.63 ± 9.0313.31 ± 6.30< 0.0001
AFP (ng/mL), Median (range)26.2 (0, 29800)31 (1, 271600)0.0625
Tumor size (mean ± SD mm)37.37 ± 25.6249.72 ± 33.140.0052
Solitary/Multiple
Solitary182 (66.67)41 (60.29)0.3230
Multiple91 (33.33)27 (39.71)
Vp
(+)74 (27.11)29 (42.65)0.0125
(-)199 (72.89)39 (57.35)
T factor
T1/2156 (57.14)32 (47.06)0.1347
T3/4117 (42.86)36 (52.94)